Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2021-01-16 2020-03-09
Drug Identification Number 02436981 02436981
Brand name MINT-OLANZAPINE ODT MINT-OLANZAPINE ODT
Common or Proper name Olanzapine Olanzapine
Company Name MINT PHARMACEUTICALS INC MINT PHARMACEUTICALS INC
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 15MG 15MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30 count Blisters 30 count Blisters
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-03-09 2020-03-09
Estimated end date Unknown
Actual end date 2021-01-15
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments